Bone mineral metabolism in adults with β-thalassaemia major and intermedia

British Journal of Haematology

Volumn 111, Issue 3, 2000, Pages 902-907

  Pollak, Rivka Dresner ^a   Rachmilewitz, Eliezer ^a   Blumenfeld, Anat ^a   Idelson, Maria ^a   Goldfarb, Ada W ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

thalassaemia; Bone mineral density; Markers of bone formation and resorption; Vitamin D receptor gene polymorphism

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE BONE ISOENZYME; COLLAGEN TYPE 1; OSTEOCALCIN; SOMATOMEDIN C; VITAMIN D RECEPTOR;

ADULT; ARTICLE; BETA THALASSEMIA; BONE ATROPHY; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; GENOTYPE; HUMAN; LUMBAR SPINE; MALE; OSTEOLYSIS; OSTEOPENIA; PRIORITY JOURNAL; RADIUS; THALASSEMIA MAJOR; VITAMIN D DEFICIENCY;

25-HYDROXYVITAMIN D 2; ADULT; ALKALINE PHOSPHATASE; BETA-THALASSEMIA; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CHI-SQUARE DISTRIBUTION; COLLAGEN; COLLAGEN TYPE I; FEMALE; FEMUR NECK; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LONGITUDINAL STUDIES; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; MINERALS; OSTEOCALCIN; PEPTIDES; POLYMORPHISM, GENETIC; RADIUS; RECEPTORS, CALCITRIOL; VITAMIN D DEFICIENCY;

EID: 0034492452     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02392.x     Document Type: Article

References (21)

1. Low serum 25 hydroxyvitamin D in hereditary hemochromatosis Relation to iron status
2. Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine
3. Longitudinal monitoring of bone mineral density in thalassemic patients: Genetic structure and osteoporosis
4. Markers of bone resorption predict hip fracture in elderly women: The EPIDOS Prospective study
5. Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women
6. Reduced bone density and osteoporosis associated with polymorphic Spl binding site in the collagen type α 1 gene
7. The role of the Sp1 polymorphism in the development of osteoporosis in patients with thalassaemia major
8. Bone mineral density in relation to polymorphism at the vitamin D receptor locus
9. Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein-3, bone isoenzyme alkaline phosphatase and forearm bone mineral content in young adults with GH deficiency of childhood onset
10. Normal growth hormone reserve in men with idiopathic osteoporosis and reduced circulating levels of insulin-like growth factor-1
11. Bone mineral density of patients with thalassaemia major: Four year follow-up
12. Prediction of bone density from vitamin D receptor alleles
13. Growth hormone and bone
14. Specificity of urinary excretion of cross-linked N-telopeptides of type 1 collagen as a marker of bone turnover
15. Short stature and failure of pubertal development in thalassaemia major: Evidence of hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion
16. Urinary N-telopeptide levels discriminate normal osteopenic and osteoporotic bone mineral density
17. Bone mineral density in prepubertal children with β thalassaemia correlation with growth and hormonal data
18. Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: A twin study in Britain
19. Serum level of insulin-like growth factor (IGF) I. IGF-binding protein (IGFBP) -2 and IGFBP-3 in osteoporotic patients with and without spinal fractures
20. Relation of alleles of the collagen type I gene to bone density and the risk of osteoporotic fractures in postmenopausal women
21. Bone disease in β thalassaemia major